首页> 外国专利> FORMULATION OF CONTROLLED LIBERATION THAT TRAMADOL FORMULATION OF CONTROLLED LIBERATION CONTAINING TRAMADOL.

FORMULATION OF CONTROLLED LIBERATION THAT TRAMADOL FORMULATION OF CONTROLLED LIBERATION CONTAINING TRAMADOL.

机译:受控解放的配方,即包含TRAMADOL的受控解放的TRAMADOL配方。

摘要

Use of tramadol in the manufacture of a controlled release analgesic preparation for once-daily oral administration, in which (a) the preparation contains between 1 and 80% weight / weight of at least one hydrophilic polymer, and an analgesically effective amount of tramadol HCl in a controlled release matrix and exhibits the following in vitro dissolution rate when measured using the Ph. Eur. Paddle Method at 100 rpm in 900 ml of 0.1 N hydrochloric acid at 37 ° C and using a UV detection at 270 nm: between 0 and 30% (by weight) of tramadol released after 1 hour, between 0 and 40% (by weight) of tramadol released after 2 hours, between 3 and 55% (by weight) of tramadol released after 4 hours, between 10 and 65% (by weight) of tramadol released after 8 hours, between 20 and 75% (by weight) of tramadol released after 12 hours, between 30 and 88% (by weight) of tramadol released after 16 hours, between e 50 and 100% (by weight) of tramadol released after 24 hours, more than 80% (by weight) of tramadol released after 36 hours; or (b) the controlled release preparation comprises a tramadol or a salt thereof incorporated into a normal release matrix, which is a spheroid comprising the pharmaceutically acceptable tramadol or salt thereof and a spheronizing agent, the spheroid having a coating of Controlled release selected from water insoluble waxes, water insoluble polymethacrylates and water insoluble cellulose.
机译:曲马多在制备用于每日一次口服给药的控释镇痛制剂中的用途,其中(a)该制剂包含1至80%重量/重量的至少一种亲水聚合物,以及镇痛有效量的曲马多HCl在控释基质中,当使用Ph.Eur测定时,其体外溶出速率如下。在37°C下在900 ml 0.1 N盐酸中以100 rpm的转速进行搅拌,并在270 nm下使用UV检测:1小时后释放的曲马多为0至30%(重量),0至40%(重量) 2小时后释放的曲马多,4小时后释放的曲马多的3至55%(重量),8小时后释放的曲马多的10至65%(重量),20%至75%(重量)的12小时后释放的曲马多,16小时后释放的曲马多介于30%至88%(按重量),24小时后释放的曲马多介于50%至100%(按重量计),超过80%(重量)的曲马多36小时后;或(b)控释制剂包括掺入正常释放基质中的曲马多或其盐,其为包含药学上可接受的曲马多或其盐和球化剂的球体,该球体具有选自水的控释包衣不溶性蜡,水不溶性聚甲基丙烯酸酯和水不溶性纤维素。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号